• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Intuitive stock down amid next-gen robot disappointment

Intuitive stock down amid next-gen robot disappointment

January 24, 2023 By Sean Whooley

Intuitive Surgical logoIntuitive Surgical (Nasdaq:ISRG) shares took a hit after an earnings call in which CEO Gary Guthart pushed back the timing of a potential next-gen surgical robotics multiport system.

“As we start this year, we do not currently expect a new multiport system launch in 2023,” Guthart said in a call with analysts this evening.

Later in the night, BTIG analysts released a note with the headline: “Multiport Head-Fake Tanks Shares Midway Through the Earnings Call; It’s Not What Many Wanted to Hear.”

ISRG shares were down more than 9% to $257.98 apiece after-hours.

“Shares tanked, and we’re scratching our heads a bit as we try to understand ISRG’s thinking. Some of the change in posture appears to be stemming from a dynamic regulatory environment (across multiple geographies), which may require clinical trials that push out clearances, but supply chain (and new component availability) also appears to be an issue,” said BTIG analysts Ryan Zimmerman and Sam Durno. The analysts still stuck with their BUY rating, but lowered their price target to $279 from a previous $316.

Intuitive also had a Q4 miss

On top of apparently pushing back the timing on a next-gen robot, Intuitive’s fourth-quarter results missed the consensus forecast.

The Sunnyvale, California-based surgical robot developer posted profits of $324.9 million. That amounts to 91¢ per share on sales of $1.655 billion for the three months ended Dec. 31, 2022. Intuitive registered a 0.3% bottom-line gain on sales growth of 6.7%.

Adjusted to exclude one-time items, earnings per share came in at $1.23. That finishes 2¢ behind projections of $1.25 apiece on Wall Street. Analysts expected sales totaling $1.68 billion.

Intuitive projects da Vinci surgical robot procedures to increase by approximately 12–16% year-over-year in 2023. This comes despite fewer placements, the company said previously. Intuitive cited a COVID-19 resurgence in China as the driving force impacting procedure volumes in the area.

When the company released its preliminary results earlier this month, CEO Gary Guthart said customers continue to grow adoption of training, products and services from Intuitive.

“We remain focused on supporting our customers’ drive to improve the quadruple aim in acute interventions,” he said.

Executive editor Chris Newmarker contributed to this report. 

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Surgical, Surgical Robotics, Wall Street Beat Tagged With: Intuitive Surgical, surgical robot, surgical robotics

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy